デフォルト表紙
市場調査レポート
商品コード
1523169

プレシジョンメディシン（精密医療）市場レポート：2030年までの動向、予測、競合分析

Precision Medicine Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
プレシジョンメディシン（精密医療）市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年07月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

プレシジョンメディシン（精密医療）の動向と予測

世界のプレシジョンメディシン市場は、2024年から2030年までのCAGRが9.5%で、2030年までに推定1,436億米ドルに達すると予想されています。この市場の主な促進要因は、個別化治療に対する需要の増加とコンパニオン診断・遺伝子検査に対する嗜好の高まりです。世界のプレシジョンメディシン市場の将来は、腫瘍、希少疾患、感染症、血液疾患市場に機会があり、有望視されています。

セグメント別のプレシジョンメディシン

本調査では、世界のプレシジョンメディシンのタイプ別、適応症別、最終用途別、地域別の予測を掲載しています。

プレシジョンメディシン市場の洞察

Lucintel社は、予測期間中、阻害薬が最大のセグメントであり続けると予測しています。

この市場において、腫瘍は予測期間中最大のセグメントであり続けると予想されます。

北米は予測期間中最大の地域であり続けると予想されます。

よくある質問

Q1.市場規模は：

A1.世界のプレシジョンメディシン市場は、2030年までに推定1,436億米ドルに達すると予想されています。

Q2.市場の成長予測は：

A2.世界のプレシジョンメディシン市場は、2024年から2030年にかけてCAGR 9.5%で成長すると予測されます。

Q3.市場の成長に影響を与える主な促進要因は：

A3.この市場の主な促進要因は、個別化治療に対する需要の増加とコンパニオン診断・遺伝子検査に対する嗜好の高まりです。

Q4.市場の主要セグメントは：

A4.プレシジョンメディシン市場の将来は、腫瘍、希少疾患、感染症、血液疾患の各市場における機会により有望視されています。

Q5.市場の主要企業は：

A5.プレシジョンメディシンの主要企業は以下の通り：

  • Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Bristol Myers Squibb
  • AstraZeneca
  • Gilead Sciences
  • AbbVie
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Sanofi

Q6.今後、最大となる市場セグメントは：

A6.Lucintel社は、予測期間中、阻害薬が最大のセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.北米は予測期間中最大の地域であり続けると予想されます。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のプレシジョンメディシン市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のプレシジョンメディシン市場の動向（2018～2023年）と予測（2024～2030年）
  • タイプ別の世界のプレシジョンメディシン市場
    • 阻害薬
    • モノクローナル抗体
    • 細胞・遺伝子治療
    • 抗ウイルス薬・抗レトロウイルス薬
    • その他
  • 適応症別の世界のプレシジョンメディシン市場
    • 腫瘍
    • 希少疾患
    • 感染症
    • 血液疾患
    • その他
  • 最終用途別の世界のプレシジョンメディシン市場
    • 病院・クリニック
    • 在宅医療

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のプレシジョンメディシン市場
  • 北米のプレシジョンメディシン市場
  • 欧州のプレシジョンメディシン市場
  • アジア太平洋地域のプレシジョンメディシン市場
  • その他地域のプレシジョンメディシン市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
  • 世界のプレシジョンメディシン市場における新たな動向
  • 戦略分析
    • 新製品の開発
    • 世界のプレシジョンメディシン市場の能力拡大
    • 世界のプレシジョンメディシン市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 主要企業の企業プロファイル

  • Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Bristol Myers Squibb
  • AstraZeneca
  • Gilead Sciences
  • AbbVie
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Sanofi
目次

Precision Medicine Trends and Forecast

The future of the global precision medicine market looks promising with opportunities in the oncology, rare disease, infectious disease, and hematological disorder markets. The global precision medicine market is expected to reach an estimated $143.6 billion by 2030 with a CAGR of 9.5% from 2024 to 2030. The major drivers for this market are increasing demand for personalized treatment and rising preference for companion diagnostics & genetic testing.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Precision Medicine by Segment

The study includes a forecast for the global precision medicine by type, indication, end use, and region.

Precision Medicine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Inhibitor Drugs
  • Monoclonal Antibodies
  • Cell & Gene Therapy
  • Antiviral & Anti-Retroviral Drugs
  • Others

Precision Medicine Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Oncology
  • Rare Diseases
  • Infectious Diseases
  • Hematological Disorders
  • Others

Precision Medicine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Home Care Settings

Precision Medicine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Precision Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies precision medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the precision medicine companies profiled in this report include-

  • Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Bristol Myers Squibb
  • AstraZeneca
  • Gilead Sciences
  • AbbVie
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Sanofi

Precision Medicine Market Insights

Lucintel forecasts that inhibitor drug will remain the largest segment over the forecast period.

Within this market, oncology will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Precision Medicine Market

Market Size Estimates: Precision medicine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Precision medicine market size by type, indication, end use, and region in terms of value ($B).

Regional Analysis: Precision medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, indications, end uses, and regions for the precision medicine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the precision medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the precision medicine market size?

Answer: The global precision medicine market is expected to reach an estimated $143.6 billion by 2030.

Q2. What is the growth forecast for precision medicine market?

Answer: The global precision medicine market is expected to grow with a CAGR of 9.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the precision medicine market?

Answer: The major drivers for this market are increasing demand for personalized treatment and rising preference for companion diagnostics & genetic testing.

Q4. What are the major segments for precision medicine market?

Answer: The future of the precision medicine market looks promising with opportunities in the oncology, rare disease, infectious disease, and hematological disorder markets.

Q5. Who are the key precision medicine market companies?

Answer: Some of the key precision medicine companies are as follows:

  • Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Bristol Myers Squibb
  • AstraZeneca
  • Gilead Sciences
  • AbbVie
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Sanofi

Q6. Which precision medicine market segment will be the largest in future?

Answer: Lucintel forecasts that inhibitor drug will remain the largest segment over the forecast period.

Q7. In precision medicine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the precision medicine market by type (inhibitor drugs, monoclonal antibodies, cell & gene therapy, antiviral & anti-retroviral drugs, and others), indication (oncology, rare diseases, infectious diseases, hematological disorders, and others), end use (hospitals & clinics and home care settings), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Precision Medicine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Precision Medicine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Precision Medicine Market by Type
    • 3.3.1: Inhibitor Drugs
    • 3.3.2: Monoclonal Antibodies
    • 3.3.3: Cell & Gene Therapy
    • 3.3.4: Antiviral & Anti-Retroviral Drugs
    • 3.3.5: Others
  • 3.4: Global Precision Medicine Market by Indication
    • 3.4.1: Oncology
    • 3.4.2: Rare Diseases
    • 3.4.3: Infectious Diseases
    • 3.4.4: Hematological Disorders
    • 3.4.5: Others
  • 3.5: Global Precision Medicine Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Home Care Settings

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Precision Medicine Market by Region
  • 4.2: North American Precision Medicine Market
    • 4.2.1: North American Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
    • 4.2.2: North American Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others
  • 4.3: European Precision Medicine Market
    • 4.3.1: European Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
    • 4.3.2: European Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others
  • 4.4: APAC Precision Medicine Market
    • 4.4.1: APAC Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
    • 4.4.2: APAC Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others
  • 4.5: ROW Precision Medicine Market
    • 4.5.1: ROW Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
    • 4.5.2: ROW Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Precision Medicine Market by Type
    • 6.1.2: Growth Opportunities for the Global Precision Medicine Market by Indication
    • 6.1.3: Growth Opportunities for the Global Precision Medicine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Precision Medicine Market by Region
  • 6.2: Emerging Trends in the Global Precision Medicine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Precision Medicine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Precision Medicine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Hoffmann-La Roche
  • 7.2: Novartis
  • 7.3: Pfizer
  • 7.4: Bristol Myers Squibb
  • 7.5: AstraZeneca
  • 7.6: Gilead Sciences
  • 7.7: AbbVie
  • 7.8: Eli Lilly and Company
  • 7.9: GlaxoSmithKline
  • 7.10: Sanofi